- Home
- CISS vs XXII Comparison
CISS vs XXII Comparison
Compare CISS & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- XXII
- Stock Information
- Founded
- CISS 2022
- XXII 1998
- Country
- CISS Greece
- XXII United States
- Employees
- CISS N/A
- XXII N/A
- Industry
- CISS Marine Transportation
- XXII Medicinal Chemicals and Botanical Products
- Sector
- CISS Consumer Discretionary
- XXII Health Care
- Exchange
- CISS Nasdaq
- XXII Nasdaq
- Market Cap
- CISS 2.4M
- XXII 2.1M
- IPO Year
- CISS N/A
- XXII N/A
- Fundamental
- Price
- CISS $3.90
- XXII $0.80
- Analyst Decision
- CISS
- XXII
- Analyst Count
- CISS 0
- XXII 0
- Target Price
- CISS N/A
- XXII N/A
- AVG Volume (30 Days)
- CISS 62.5K
- XXII 1.6M
- Earning Date
- CISS 05-27-2025
- XXII 05-14-2025
- Dividend Yield
- CISS N/A
- XXII N/A
- EPS Growth
- CISS N/A
- XXII N/A
- EPS
- CISS N/A
- XXII N/A
- Revenue
- CISS $42,296,101.00
- XXII $24,382,000.00
- Revenue This Year
- CISS N/A
- XXII $19.23
- Revenue Next Year
- CISS N/A
- XXII $81.05
- P/E Ratio
- CISS N/A
- XXII N/A
- Revenue Growth
- CISS 47.17
- XXII N/A
- 52 Week Low
- CISS $2.85
- XXII $0.70
- 52 Week High
- CISS $29.40
- XXII $265.95
- Technical
- Relative Strength Index (RSI)
- CISS 50.21
- XXII 26.33
- Support Level
- CISS $3.20
- XXII $0.70
- Resistance Level
- CISS $3.58
- XXII $0.83
- Average True Range (ATR)
- CISS 0.37
- XXII 0.21
- MACD
- CISS 0.10
- XXII 0.05
- Stochastic Oscillator
- CISS 70.50
- XXII 5.92
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.